SRX3207
Catalog Number | Pack Size | List Price* | Quantity | |
---|---|---|---|---|
HY-136198-5MG | 5 mg | 571,00 | Add | |
HY-136198-10MG | 10 mg | 961,00 | Add | |
HY-136198-25MG | 25 mg | 1'895,00 | Add | |
HY-136198-50MG | 50 mg | 3'079,00 | Add | |
HY-136198-100MG | 100 mg | 4'751,00 | Add |
* CHF, excl. 8.1% VAT and shipping costs
Product Description
Best price guarantee – we offer you the lowest price in Switzerland. Please contact us for a quote if needed.
SRX3207 is an orally active and first-in-class dual Syk/PI3K inhibitor, with IC50 values of 10.7 nM and 861 nM for Syk and PI3Kα, respectively. SRX3207 relieves tumor immunosuppression[1][2].
Category | Biochemicals |
Supplier | MedChem Express |
Regulatory Status | RUO |
Research Field | Cancer, PI3K/Akt/mTOR,Protein Tyrosine Kinase/RTK |
Format | Solubility: DMSO : 5 mg/mL (ultrasonic) |
Grade | Clinical information: No Development Reported |
Purity | 98.5% |
Molecular Formula | C29H29N7O3S |
Molecular Weight | 555.65 |
CAS-Number | 2254693-15-5 |
Storage Conditions | -20°C, 3 years; 4°C, 2 years (Powder) |
Tech. Data Sheet | View datasheet |
Link To Supplier | http://www.medchemexpress.com |
Shipping Details | Room Temperature |
Material Safety Data Sheet | Download PDF |